A method for constructing heterogeneous coordination interfaces using Fe-doped oxygen-rich vacancy δ-MnO2 induced by 2-pyridinecarboxylic acid to activate periodate degradation of organic pollutants.

By inducing Fe doping with oxygen-rich vacancy δ-MnO2 to construct a heterogeneous coordination interface using 2-pyridinecarboxylic acid, a PICA-Mn(Ⅳ) complex intermediate is formed, which solves the problem of insufficient stability of Mn(Ⅲ) intermediate in existing manganese-based catalysts and achieves the effect of efficient degradation of organic pollutants.

CN123105831APending Publication Date: 2026-11-17GUANGDONG UNIV OF TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611406409.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-11
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing manganese-based catalysts in advanced oxidation water treatment suffer from short lifespan of Mn(III) intermediates, limited stability, easy disproportionation, and complex reaction pathways, which limit the generation efficiency of high-valence manganese oxygen species and the degradation efficiency of pollutants, making it difficult to effectively degrade antibiotic and pharmaceutical organic pollutants.

Method used

A heterogeneous coordination interface is constructed by inducing Fe doping with oxygen-rich vacancy δ-MnO2 using 2-pyridinecarboxylic acid, forming a PICA-Mn(Ⅳ) complex intermediate. Periodate undergoes interfacial electron transfer at the Mn/Fe active site, generating pentavalent manganese oxygen species and pentavalent iron oxygen species, thereby achieving the oxidative degradation of organic pollutants.

Benefits of technology

Rapid degradation of organic pollutants is achieved at mild pH and low periodate concentrations, reducing the risk of metal loss and improving the structural stability and reusability of the catalyst.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123105831A_ABST
    Figure CN123105831A_ABST
Patent Text Reader

Abstract

A method for activating periodate degradation of organic pollutants by constructing a heterogeneous coordination interface using Fe-doped oxygen-rich vacancy δ-MnO2 induced by 2-pyridinecarboxylic acid (PCA) involves adding a PCA catalyst, 2-pyridinecarboxylic acid, and periodate to water containing organic pollutants. PCA then coordinates with the Mn sites on the surface of the PCA catalyst to form a non-leached heterogeneous surface PICA-Mn(Ⅳ) complex intermediate. Periodate accumulates near the active sites on the surface of the PICA-Mn(Ⅳ) complex intermediate. Interfacial electron transfer and I-O bond activation occur at the Mn / Fe active sites, inducing the formation of pentavalent manganese oxide and pentavalent iron oxide species within the PICA-Mn(Ⅳ) complex intermediate, ultimately achieving the oxidative degradation of organic pollutants. This invention utilizes 2-pyridinecarboxylic acid to form a Mn-N / O bidentate coordination heterogeneous interface on the Fe-doped oxygen-rich vacancy δ-MnO2 surface, generating pentavalent manganese and iron-oxygen species. This can degrade organic pollutants with low oxidant content, resulting in low metal leaching and a recyclable catalyst.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of advanced oxidation technology in water treatment, and in particular to a method for constructing a heterogeneous coordination interface by 2-pyridinecarboxylic acid-induced Fe-doped oxygen-rich vacancy δ-MnO2 to activate periodate degradation of organic pollutants. Background Technology

[0002] Antibiotic and pharmaceutical-related organic pollutants are widely found in pharmaceutical wastewater, hospital wastewater, aquaculture wastewater, and municipal sewage. These pollutants typically exhibit stable molecular structures, poor biodegradability, and strong environmental persistence, making them difficult to remove rapidly and completely using conventional water treatment processes such as biological treatment, adsorption, and coagulation. Therefore, developing efficient, stable, and suitable technologies for removing organic pollutants in complex aquatic environments is of great significance.

[0003] Advanced oxidation processes (AOPs) are widely used for the removal of recalcitrant organic pollutants due to their ability to generate highly reactive oxidizing species in situ. Among these, periodate-based AOP systems have attracted considerable attention in recent years. Periodate, as an iodine-containing oxidant, exhibits good storage stability and strong oxidizing power. Under the action of a catalyst, it can be activated to generate various reactive oxide species, thereby achieving the oxidative degradation of organic pollutants. However, the oxidizing power of periodate alone is limited, and transition metal catalysts are typically required to promote interfacial electron transfer and I–O bond activation.

[0004] Manganese-based catalytic materials have attracted attention in the field of advanced oxidation water treatment due to their advantages such as variable valence state, environmental friendliness, and low cost. In existing manganese-based oxidation systems, Mn(III) complexes are often considered important intermediates for the formation of high-valence manganese oxygen species. However, Mn(III) intermediates typically suffer from problems such as short lifetime, limited stability, susceptibility to disproportionation, or complex reaction pathways, which limit the efficiency of high-valence manganese oxygen species formation and pollutant degradation.

[0005] Manganese dioxide (MDC) is a typical manganese-based catalytic material, characterized by variable valence state, structural stability, and environmental friendliness, and has a good foundation for application in advanced oxidation water treatment. Existing MDC catalysts often improve their catalytic activity through metal doping, oxygen vacancy construction, crystal form regulation, or morphology optimization. However, these modification methods mainly affect the number of active sites and electron transport capacity on the catalyst surface, and their control over the electron spin state of the metal center, surface ligand complexation behavior, and the generation pathway of high-valence metal oxygen species during periodate activation remains insufficient.

[0006] Therefore, in view of the shortcomings of the existing technology, there is an urgent need to provide a method for constructing a heterogeneous coordination interface for periodate degradation of organic pollutants by inducing Fe doping with oxygen-rich vacancy δ-MnO2 in the form of 2-pyridinecarboxylic acid, so as to overcome the defects of the existing technology. Summary of the Invention

[0007] The purpose of this invention is to overcome at least one of the shortcomings of existing technologies and provide a method for activating periodate degradation of organic pollutants by constructing a heterogeneous coordination interface on Fe-doped oxygen-rich vacancy δ-MnO2 induced by 2-pyridinecarboxylic acid. This method activates periodate by constructing a heterogeneous Mn-N / O bidentate coordination interface on the surface of Fe-doped oxygen-rich vacancy δ-MnO2 with 2-pyridinecarboxylic acid, bypassing the Mn(III) intermediate pathway, enabling rapid degradation of organic pollutants, and exhibiting both low metal leaching and good cycling stability.

[0008] The present invention achieves the above objectives through the following technical solutions: This invention provides a method for the degradation of organic pollutants by activating the heterogeneous coordination interface of Fe-doped oxygen-rich vacancy δ-MnO2 induced by 2-pyridinecarboxylic acid. The method involves adding Fe-doped oxygen-rich vacancy δ-MnO2 catalyst, 2-pyridinecarboxylic acid, and periodate to water containing organic pollutants. Then, 2-pyridinecarboxylic acid coordinates with the Mn sites on the surface of the Fe-doped oxygen-rich vacancy δ-MnO2 catalyst to form a non-leached heterogeneous surface PICA-Mn(Ⅳ) complex intermediate. Periodate accumulates near the surface active sites of the heterogeneous surface PICA-Mn(Ⅳ) complex intermediate. At the Mn / Fe active sites, periodate undergoes interfacial electron transfer and Io bond activation, inducing the generation of pentavalent manganese oxygen species and pentavalent iron oxygen species in the heterogeneous surface PICA-Mn(Ⅳ) complex intermediate, ultimately achieving the oxidative degradation of organic pollutants.

[0009] The Fe-doped oxygen-rich vacancy δ-MnO2 catalyst contains a δ-MnO2 host structure, Fe species doped in the δ-MnO2 host structure, and surface oxygen vacancies.

[0010] The Fe-doped oxygen-rich vacancy δ-MnO2 catalyst is prepared by reacting potassium permanganate, soluble iron salt and ethylene glycol to generate an Fe-doped manganese dioxide precursor, which is then reduced by a reducing agent.

[0011] In the water body, the concentration of periodate is 20 μmol / L to 120 μmol / L, the dosage of Fe-doped oxygen-rich vacancy δ-MnO2 catalyst is 20 mg / L to 100 mg / L, and the concentration of 2-pyridinecarboxylic acid is 0.3 mmol / L to 1.0 mmol / L.

[0012] In the water body, the pH value of the reaction is 4 to 6, and the reaction time is 1 min to 5 min.

[0013] In the water body, the concentration of periodate was 45 μmol / L.

[0014] Preferably, the periodate is at least one of sodium periodate, potassium periodate, or periodic acid.

[0015] Preferably, the aforementioned organic pollutants include at least one of sulfamethoxazole (SMZ), norfloxacin (NFX), carbamazepine (CBZ), or naproxen (NPX).

[0016] Preferably, the above-mentioned Fe-doped oxygen-rich vacancy δ-MnO2 catalyst is prepared by the following steps: S1. Add potassium permanganate to deionized water to obtain potassium permanganate solution A; add soluble iron salt to ethylene glycol to obtain iron salt solution B; S2. Under stirring conditions, the iron salt solution B obtained in step S1 is added to the potassium permanganate solution A obtained in step S1 to obtain the Fe-doped manganese dioxide precursor. S3. Dissolve the reducing agent in deionized water to obtain a reducing agent solution; add the Fe-doped manganese dioxide precursor obtained in step S2 to the reducing agent solution for reduction treatment to obtain the Fe-doped oxygen-rich vacancy δ-MnO2 catalyst.

[0017] In step S2, the molar ratio of the soluble iron salt to potassium permanganate is (0.03-0.17):1.

[0018] In step S3, the mass ratio of sodium borohydride to Fe-doped δ-MnO2 precursor is (3.1~12.6):1.

[0019] In step S3, the reduction treatment temperature is 15℃~35℃, and the reduction treatment time is 12min~18min.

[0020] Preferably, the soluble iron salt is at least one of ferric nitrate, ferric nitrate hydrate, ferric chloride, ferric chloride hydrate, ferric sulfate, ferric sulfate hydrate, ferric acetate, and ferric acetate hydrate.

[0021] Preferably, the reducing agent is sodium borohydride.

[0022] The beneficial effects of this invention are: 1. This invention confines the coordination activation process induced by 2-pyridinecarboxylic acid to the heterogeneous surface Mn sites of Fe-doped oxygen-rich vacancy δ-MnO2, forming a non-leaching PICA-Mn(Ⅳ) surface complex structure, which differs from the homogeneous activation system formed by Mn ions and PICA in traditional solutions. This structure helps reduce the risk of metal ion residue and catalytic component loss, while improving the stability of active sites at the solid-liquid interface. In this invention, the 2-pyridinecarboxylic acid coordinates with the Mn sites on the catalyst surface through pyridine nitrogen and carboxyl oxygen, forming a heterogeneous surface coordination structure, wherein pyridine nitrogen and carboxyl oxygen jointly participate in the coordination of Mn sites, forming a Mn-N / O bidentate coordination environment.

[0023] 2. This invention utilizes Fe doping and oxygen vacancies to synergistically regulate the electronic structure and spin state of Mn sites on the δ-MnO2 surface, forming high-spin Mn active sites with enhanced Mn 3d orbital spin polarization characteristics. Compared to Fe doping or oxygen vacancies alone, this coupling effect produces a synergistic catalytic effect that is not simply additive, providing a more favorable electronic structure environment for periodate interface activation.

[0024] 3. The heterogeneous surface PICA-Mn(Ⅳ) complex intermediate promotes the enrichment of periodate near the surface active sites of the heterogeneous surface PICA-Mn(Ⅳ) complex intermediate. Periodate undergoes interfacial electron transfer and IO bond activation at the Mn / Fe active sites, generating pentavalent manganese oxygen species and pentavalent iron oxygen species. This surface coordination structure, synergistically with the high-spin Mn active center, can improve the activation efficiency of periodate at low concentrations, achieving rapid degradation of organic pollutants.

[0025] 4. This invention induces the generation of pentavalent manganese oxygen species and pentavalent iron oxygen species through a heterogeneous surface PICA-Mn(Ⅳ) complexation intermediate; no characteristic absorption peak of stable Mn(Ⅲ) intermediate was detected during the reaction, indicating that the system of this invention is significantly different from the traditional manganese-based oxidation pathway that relies on the accumulation of Mn(Ⅲ) intermediate, and provides a new mechanism for surface coordination to regulate the generation of high-valence metal oxygen species.

[0026] 5. The catalytic system of this invention can achieve rapid degradation of organic pollutants under mild pH, low periodate concentration, and low metal leaching conditions, and exhibits good structural stability and reusability. Therefore, it not only improves the pollutant degradation efficiency, but also reduces the potential metal loss problem in homogeneous metal complex systems by constructing a stable heterogeneous interface. Attached Figure Description

[0027] The invention will be further described with reference to the accompanying drawings, but the contents of the drawings do not constitute any limitation on the invention.

[0028] Figure 1 The XRD patterns of Fe-doped oxygen-rich vacancy δ-MnO2 catalysts and comparative examples are shown.

[0029] Figure 2 The images show SEM and TEM images of Fe-doped oxygen-vacancy-rich δ-MnO2 catalysts and comparative examples. Figure 2 (a) and Figure 2 (b) SEM images of the 30Fe-Ov1 / 2-MnO2 catalyst under different fields of view. Figure 2 (c) is a TEM image of the 30Fe-Ov1 / 2-MnO2 catalyst.

[0030] Figure 3The images show the O1s XPS spectra and oxygen vacancy EPR characterization of the Fe-doped oxygen-vacancy-rich δ-MnO2 catalyst and the comparative example.

[0031] Figure 4 The images show the electronic structure and spin state analysis of the Fe-doped oxygen-rich vacancy δ-MnO2 catalyst and the high-spin Mn active sites in the comparative example. Figure 4 (a) is the orbital projected density of states (PDOS) analysis plot for Mn 3d. Figure 4 (b) is the fitted curve of magnetic susceptibility at varying temperatures. Figure 4 (c) is a schematic diagram of the electronic structure of the low-spin / high-spin state.

[0032] Figure 5 30Fe-Ov 1 / 2 An analytical diagram illustrating the formation of PICA-Mn(Ⅳ) related complex intermediates, pentavalent manganese oxygen species, and pentavalent iron oxygen species in the MnO2 / PICA / PI heterogeneous system. Figure 5 (a) shows the results of the PMSO oxygen atom transfer probe. Figure 5 (b) shows the results of the Ph2SO oxygen atom transfer probe. Figure 5 (c) is the in-situ UV-Vis spectrum analysis diagram. Figure 5 (d) is a graph showing the changes in characteristic absorption of Mn(Ⅳ) at different reaction times.

[0033] Figure 6 This is a comparison chart of the performance of Fe-doped oxygen-rich vacancy δ-MnO2 catalysts in the PICA / PI system for degrading SMZ. Figure 6 (a) is 10Fe-Ov 1 / 2 -MnO2、30Fe-Ov 1 / 2 -MnO2 and 50Fe-Ov 1 / 2 Comparison of the performance of MnO2 in degrading SMZ in the PICA / PI system. Figure 6 (b) 30Fe-Ov prepared using ferric chloride, ferric sulfate, ferric nitrate and ferric acetate as iron sources, respectively. 1 / 2 - Comparison of the performance of MnO2 catalyst in the PICA / PI system for degrading SMZ.

[0034] Figure 7 30Fe-Ov 1 / 2 -MnO2, 30Fe-MnO2 and Ov 1 / 2 Comparison of the degradation performance of SMZ by MnO2 in the PICA / PI system.

[0035] Figure 8 For different reaction conditions of 30Fe-Ov 1 / 2 The test results of the effect of the MnO2 / PICA / PI system on the degradation performance of SMZ, among which Figure 8(a) The degradation process of SMZ under different catalyst dosages and different periodate dosages; Figure 8 (b) shows the SMZ degradation process under the influence of different organic acid ligands on the catalytic performance of the system. Figure 8 (c) shows the effect of different 2-pyridinecarboxylic acid concentrations on the degradation performance of SMZ in the system.

[0036] Figure 9 30Fe-Ov 1 / 2 -Performance test diagram of MnO2 in the PICA / PI system for degrading different typical organic micropollutants.

[0037] Figure 10 30Fe-Ov 1 / 2 Cyclic stability and metal leaching test results of MnO2. Figure 10 (a) is 30Fe-Ov 1 / 2 Cyclic degradation performance test of MnO2 catalyst Figure 10 (b) is the test of the leaching concentration of Fe and Mn elements during the cycle. Detailed Implementation

[0038] The technical solution of the present invention will be further explained with reference to the following preparation examples. Unless otherwise specified, the experimental methods in the following preparation examples are conventional methods.

[0039] Preparation Example 1

[0040] A method for preparing an Fe-doped oxygen-rich vacancy δ-MnO2 catalyst includes the following steps: S1. Weigh 5 mmol of potassium permanganate, add it to 100 mL of deionized water, and stir until completely dissolved to obtain potassium permanganate solution A; weigh 0.5 mmol of ferric nitrate nonahydrate, add it to 10 mL of ethylene glycol, and stir until completely dissolved to obtain ferric salt solution B, where the molar ratio of soluble ferric salt to potassium permanganate is 0.10:1. S2. Under the condition of stirring speed of 1000 rpm, the iron salt solution B obtained in step S1 is added to the potassium permanganate solution A obtained in step S1, and then stirring is continued at 1000 rpm for 1 h. After the reaction is completed, the solid is separated, and then the solid is washed with 100 mL of deionized water and dried at 60 °C for 12 h to obtain the Fe-doped manganese dioxide precursor, which is denoted as 30Fe-MnO2. S3. 0.3783 g of sodium borohydride was dissolved in 20 mL of deionized water to obtain a sodium borohydride solution. 60 mg of the Fe-doped manganese dioxide precursor obtained in step S2 was added to the sodium borohydride solution, i.e., the mass ratio of sodium borohydride to Fe-doped δ-MnO2 precursor was 6.3:1. The reaction was stirred at 25 °C for 15 min to form oxygen vacancies on the surface of the Fe-doped δ-MnO2, thereby regulating the spin-electronic structure of Mn-related active sites. After the reaction, the solid was filtered, washed successively with 100 mL of deionized water and 100 mL of anhydrous ethanol, and dried at 60 °C for 12 h to obtain the Fe-doped oxygen-vacancy-rich δ-MnO2 catalyst, denoted as 30Fe-Ov. 1 / 2 -MnO2.

[0041] Preparation Example 2

[0042] A method for preparing an Fe-doped oxygen-rich vacancy δ-MnO2 catalyst, which is otherwise the same as in Preparation Example 1, except that: In step S1, the amount of ferric nitrate nonahydrate is 0.167 mmol, and the molar ratio of soluble iron salt to potassium permanganate is 0.03:1, resulting in the Fe-doped δ-MnO2 precursor. In step S3, the Fe-doped oxygen-vacancy-rich δ-MnO2 catalyst obtained after reduction treatment with sodium borohydride is denoted as 10Fe-Ov. 1 / 2 -MnO2.

[0043] Preparation Example 3

[0044] A method for preparing an Fe-doped oxygen-rich vacancy δ-MnO2 catalyst, which is otherwise the same as in Preparation Example 1, except that: In step S1, the amount of ferric nitrate nonahydrate is 0.833 mmol, and the molar ratio of soluble iron salt to potassium permanganate is 0.17:1, resulting in the Fe-doped δ-MnO2 precursor. In step S3, the Fe-doped oxygen-rich vacancy δ-MnO2 catalyst obtained after sodium borohydride reduction treatment is designated as 50Fe-Ov. 1 / 2 -MnO2.

[0045] Preparation Example 4

[0046] A method for preparing a Fe-doped oxygen-vacancy-rich δ-MnO2 catalyst is described, with other characteristics identical to Preparation Example 1, except that in step S3, the amount of sodium borohydride is 0.18915 g, and the amount of Fe-doped manganese dioxide precursor is 60 mg, i.e., the mass ratio of sodium borohydride to Fe-doped δ-MnO2 precursor is 3.1:1. The reaction is stirred at 15 °C for 12 min to form oxygen vacancies on the surface of Fe-doped δ-MnO2, thereby regulating the spin-electronic structure of Mn-related active sites. After the reaction, the solid is filtered, washed successively with deionized water and anhydrous ethanol, and dried at 60 °C for 12 h. The Fe-doped oxygen-vacancy-rich δ-MnO2 catalyst obtained after reduction treatment with sodium borohydride is designated as 30Fe-Ov. 1 / 4 -MnO2.

[0047] Preparation Example 5

[0048] A method for preparing a Fe-doped oxygen-rich vacancy δ-MnO2 catalyst is described, with other features being the same as in Preparation Example 1, except that in step S3, the amount of sodium borohydride is 0.7566 g and the amount of Fe-doped manganese dioxide precursor is 60 mg, i.e., the mass ratio of sodium borohydride to Fe-doped δ-MnO2 precursor is 12.6:1. The reaction is stirred at 35 °C for 18 min to form oxygen vacancies on the surface of Fe-doped δ-MnO2, thereby regulating the spin-electronic structure of Mn-related active sites. After the reaction is completed, the solid is filtered, washed successively with deionized water and anhydrous ethanol, dried at 60 °C for 12 h, and the Fe-doped oxygen-rich vacancy δ-MnO2 catalyst obtained after sodium borohydride reduction treatment is designated as 30Fe-Ov-MnO2.

[0049] Preparation Example 6

[0050] A method for preparing an Fe-doped oxygen-rich vacancy δ-MnO2 catalyst is disclosed, which is otherwise identical to Preparation Example 1, except that the 0.5 mmol ferric nitrate nonahydrate in step S1 of Preparation Example 1 is replaced with 0.5 mmol ferric chloride hexahydrate. Specifically, 0.1352 g of ferric chloride hexahydrate is weighed and added to 10 mL of ethylene glycol, stirred until completely dissolved, to obtain iron salt solution B. Subsequent steps are the same as in Preparation Example 1, to prepare an Fe-doped oxygen-rich vacancy δ-MnO2 catalyst using ferric chloride hexahydrate as the iron source.

[0051] Preparation Example 7

[0052] A method for preparing an Fe-doped oxygen-rich vacancy δ-MnO2 catalyst is described, with other features identical to Preparation Example 1, except that the 0.5 mmol ferric nitrate nonahydrate in step S1 of Preparation Example 1 is replaced with 0.25 mmol ferric sulfate. Specifically, 0.1 g of ferric sulfate is weighed and added to 10 mL of ethylene glycol, stirred until completely dissolved, yielding an iron salt solution B. Since 0.25 mmol ferric sulfate can provide 0.5 mmol of ferric ions, the resulting ferric ion concentration is the same as in Preparation Example 1. Subsequent steps are the same as in Preparation Example 1, thus preparing an Fe-doped oxygen-rich vacancy δ-MnO2 catalyst using ferric sulfate as the iron source.

[0053] Preparation Example 8

[0054] A method for preparing an Fe-doped oxygen-rich vacancy δ-MnO2 catalyst is disclosed, which is otherwise identical to Preparation Example 1, except that the 0.5 mmol ferric nitrate nonahydrate in step S1 of Preparation Example 1 is replaced with 0.5 mmol ferric acetate. Specifically, 0.1165 g of ferric acetate is weighed and added to 10 mL of ethylene glycol, and stirred until completely dissolved to obtain an iron salt solution B. Subsequent steps are the same as in Preparation Example 1 to prepare an Fe-doped oxygen-rich vacancy δ-MnO2 catalyst using ferric acetate as the iron source.

[0055] Comparative Example 1

[0056] A method for preparing an Fe-free δ-MnO2 catalyst comprises the following steps: 5 mmol of potassium permanganate is weighed and added to 100 mL of deionized water, stirred until completely dissolved to obtain a potassium permanganate solution; 10 mL of ethylene glycol is added to the solution, and the reaction is continued to be stirred for 1 h; after the reaction is completed, the solid is filtered, washed with deionized water, and dried at 60 °C for 12 h to obtain the Fe-free δ-MnO2 catalyst, which is denoted as δ-MnO2.

[0057] Comparative Example 2

[0058] A method for preparing an Fe-doped δ-MnO2 catalyst without reduction treatment, wherein the other steps are the same as steps S1 to S2 in Preparation Example 1, except that the sodium borohydride reduction treatment in step S3 is not performed, and the resulting catalyst is denoted as 30Fe-MnO2.

[0059] Comparative Example 3

[0060] A method for preparing an undoped Fe-rich oxygen-vacancy δ-MnO2 catalyst is described, with other steps identical to Comparative Example 1, except that the undoped Fe-rich δ-MnO2 catalyst obtained in Comparative Example 1 is reduced in sodium borohydride solution under the same conditions as step S3 in Preparation Example 1. After the reaction, the solid is filtered, washed sequentially with deionized water and anhydrous ethanol, and dried at 60°C for 12 h to obtain the undoped Fe-rich oxygen-vacancy δ-MnO2 catalyst, denoted as Ov. 1 / 2 -MnO2.

[0061] Example 1

[0062] 1. Structural and oxygen vacancy characterization analysis

[0063] X-ray diffraction was used to analyze 30Fe-MnO2 from Comparative Example 2 and fresh 30Fe-O2 from Preparation Example 1. 1 / 2 -MnO2, 30Fe-Ov already used 1 / 2 The crystal structure of δ-MnO2 and the control sample of Comparative Example 1 were characterized to obtain... Figure 1 .from Figure 1 The results show that the 30Fe-Ov prepared in Example 1... 1 / 2 -MnO2 exhibits characteristic diffraction peaks of δ-MnO2, indicating that iron doping and sodium borohydride reduction treatment did not destroy the main crystal structure of manganese dioxide.

[0064] The 30Fe-Ov of Preparation Example 1 was studied using scanning electron microscopy or transmission electron microscopy. 1 / 2 Morphological observation of -MnO2 yielded... Figure 2 .from Figure 2 The results show that the catalyst obtained by the present invention can maintain the granular or blocky aggregate morphology of manganese dioxide, and the Fe doping and reduction treatment do not significantly damage the overall morphology and structure of the catalyst.

[0065] X-ray photoelectron spectroscopy was used to analyze the 30Fe-Ov prepared in Example 1. 1 / 2 -MnO2, 30Fe-MnO2 of Comparative Example 2, 30Fe-Ov-MnO2 of Preparation Example 5, and 30Fe-Ov of Preparation Example 4 1 / 4 Surface elemental analysis and oxygen vacancy analysis were performed on MnO2 and 30Fe-MnO2 (Comparative Example 2) to obtain... Figure 3 .from Figure 3 The data indicates that 30Fe-Ov 1 / 2 The oxygen vacancy-related oxygen ratio on the MnO2 surface was 45.05%, higher than that of Fe-MnO2 (27.29%) and MnO2 (28.31%). Oxygen vacancy EPR testing showed that 30Fe-Ov... 1 / 2-MnO2 exhibits a strong defect correlation signal of g≈2.002, indicating that Fe doping and sodium borohydride reduction treatment synergistically improve the surface oxygen vacancy content.

[0066] 2. Analysis of high-spin Mn active sites

[0067] To verify the synergistic regulatory effect of Fe doping and oxygen vacancy construction on the electronic structure and spin state of Mn-related active sites, the 30Fe-Ov prepared in Example 1 was analyzed. 1 / 2 Electronic structure and spin state analysis of δ-MnO2 and Comparative Example 1 yielded... Figure 4 .

[0068] pass Figure 4 This indicates that, with 30Fe-MnO2 and Ov 1 / 2 Compared to -MnO2, 30Fe-Ov 1 / 2 In δ-MnO2, the 3d suborbitals of Mn exhibit stronger spin polarization and a higher degree of unpaired electron involvement. Temperature-dependent magnetic susceptibility fitting results show that δ-MnO2 and 30Fe-Ov... 1 / 2 The effective magnetic moments of MnO2 are 4.15 μB and 4.47 μB, respectively, and the number of unpaired electrons increases from 3.27 to 3.58. The apparent electron count... g The fill factor increased from approximately 0.64 to 0.79.

[0069] The above results demonstrate that Fe doping and oxygen vacancy construction can synergistically induce Mn(III)-related d-orbital rearrangement, causing local Mn-related sites to evolve from relatively low-spin states to high-spin polarization states. These high-spin Mn-related active sites promote the enrichment of periodate near the surface active sites of the heterogeneous surface PICA-Mn(IV) complex intermediate. Periodate undergoes interfacial electron transfer and IO bond activation at the Mn / Fe active sites, thus providing favorable conditions for the formation of pentavalent manganese-oxygen and pentavalent iron-oxygen species.

[0070] Example 1

[0071] A method for activating periodate degradation of organic pollutants by constructing a heterogeneous coordination interface using Fe-doped oxygen-rich vacancy δ-MnO2 induced by 2-pyridinecarboxylic acid: Fe-doped oxygen-rich vacancy δ-MnO2 catalyst, 2-pyridinecarboxylic acid, and periodate are added to water containing organic pollutants. Then, 2-pyridinecarboxylic acid coordinates with the Mn sites on the surface of the Fe-doped oxygen-rich vacancy δ-MnO2 catalyst to form a non-leached heterogeneous surface PICA-Mn(Ⅳ) complex intermediate. Periodate accumulates near the surface active sites of the heterogeneous surface PICA-Mn(Ⅳ) complex intermediate. Interfacial electron transfer and IO bond activation occur at the Mn / Fe active sites, inducing the generation of pentavalent manganese oxygen species and pentavalent iron oxygen species in the heterogeneous surface PICA-Mn(Ⅳ) complex intermediate, ultimately achieving the oxidative degradation of organic pollutants.

[0072] In the water body, the concentration of periodate is 20 μmol / L to 120 μmol / L, the dosage of Fe-doped oxygen-rich vacancy δ-MnO2 catalyst is 20 mg / L to 100 mg / L, the concentration of 2-pyridinecarboxylic acid is 0.3 mmol / L to 1.0 mmol / L, the pH of the reaction in the water body is 4 to 6, and the reaction time is 1 min to 5 min.

[0073] This method confines the coordination activation process induced by 2-pyridinecarboxylic acid to the heterogeneous surface Mn sites of Fe-doped oxygen-rich vacancy δ-MnO2. 2-pyridinecarboxylic acid coordinates with the Mn sites on the catalyst surface through pyridine nitrogen and carboxyl oxygen, forming a Mn-N / O bidentate coordination environment and a non-leaching PICA-Mn(Ⅳ) surface complex structure. This method is different from the homogeneous activation system formed by Mn ions and PICA in traditional solutions. It reduces the risk of metal ion residue and catalytic component loss, and improves the stability of active sites at the solid-liquid interface. Fe doping and oxygen vacancies synergistically regulate the electronic structure and spin state of Mn sites on the δ-MnO2 surface, forming high-spin Mn active sites with enhanced Mn 3d orbital spin polarization. The coupling of these two elements produces a non-simple additive synergistic catalytic effect, providing a favorable electronic environment for periodate interface activation. The heterogeneous surface PICA-Mn(Ⅳ) complex intermediate promotes the enrichment of periodate near the surface active sites. Periodate undergoes interfacial electron transfer at the Mn / Fe active sites, activating the IO bond and generating pentavalent manganese oxygen and pentavalent iron oxygen species. This surface coordination structure, synergistically with the high-spin Mn active centers, enhances the activation efficiency of periodate under low concentration conditions, enabling rapid degradation of organic pollutants. No characteristic absorption peaks of stable Mn(Ⅲ) intermediates were detected during the reaction process, clearly distinguishing the system from traditional manganese-based oxidation pathways that rely on the accumulation of Mn(Ⅲ) intermediates. Moreover, this catalytic system can rapidly degrade organic pollutants under mild pH, low periodate concentration and low metal leaching conditions. The catalyst has good structural stability and reusability. By constructing a stable heterogeneous interface, it effectively alleviates the metal loss problem existing in homogeneous metal complex systems.

[0074] Example 2

[0075] 1. Analysis of PICA-Mn(Ⅳ) complex intermediates and pentavalent metal oxygen species on heterogeneous surfaces

[0076] To demonstrate the key intermediate and active oxide species in the 2-pyridinecarboxylic acid-assisted periodate activation process of Example 1, 30Fe-Ov from Preparation Example 1 was used. 1 / 2 Oxygen atom transfer probe experiments and in-situ UV-Vis absorption spectroscopy analysis were performed using a MnO2, PICA, and PI system. In the figure, PICA represents 2-pyridinecarboxylic acid, and PI represents periodate.

[0077] PMSO and Ph₂SO were used as oxygen atom transfer probes to analyze high-valence metal oxygen species in the system, and the results were as follows: Figure 5 As shown.

[0078] Figure 5 This indicates that in 30Fe-Ov 1 / 2In the MnO2, PICA, and PI system, the stoichiometric yield of PMSO2 generated by the oxidation of PMSO2 reached 97.93%, indicating a significant oxygen atom transfer process and the participation of high-valent Mn / Fe oxygen species in the system. Ph2SO2 decreased from about 105 μM to about 47 μM within 25 min, while Ph2SO2 accumulated to about 50 μM, further supporting the participation of pentavalent iron oxygen species in the reaction process.

[0079] In-situ UV-Vis absorption spectroscopy results show that in 30Fe-Ov 1 / 2 During the reaction of MnO2, PICA, and PI, no characteristic absorption peaks of stable Mn(III) intermediates at 258 nm or 270 nm were detected. Instead, characteristic absorption signals related to Mn(IV) appeared in the 300–450 nm region, accompanied by a color change in the reaction solution. This result indicates that the formation of pentavalent manganese oxide species in the system of this invention does not primarily rely on the accumulation of stable Mn(III) intermediates.

[0080] Based on the coordination characteristics of pyridine nitrogen and carboxyl oxygen in the 2-pyridinecarboxylic acid molecule and the aforementioned probe and in-situ spectral results, it is known that 2-pyridinecarboxylic acid can coordinate with Mn(Ⅳ) sites on the catalyst surface to form a heterogeneous surface PICA-Mn(Ⅳ) complex intermediate. This heterogeneous surface PICA-Mn(Ⅳ) complex intermediate promotes the adsorption of periodate near the active sites on the catalyst surface, interfacial electron transfer, and I–O bond activation by regulating the coordination environment and electronic structure of Mn sites on the catalyst surface. Furthermore, it acts as a precursor for the formation of pentavalent manganese oxygen species, inducing the formation of pentavalent manganese oxygen and pentavalent iron oxygen species. These results indicate that the system of this invention differs from the traditional manganese-based oxidation pathway that relies on the accumulation of stable Mn(Ⅲ) intermediates.

[0081] 2. Performance test of catalytic degradation of SMZ

[0082] The Fe-doped oxygen-rich vacancy δ-MnO2 catalysts prepared in Examples 1 to 3 were used to test the performance of SMZ degradation induced by 2-pyridinecarboxylic acid in the heterogeneous activation of periodate according to Example 1.

[0083] The test method is as follows: Prepare 100 mL of SMZ solution with a concentration of 2 mg / L, add 5 mg of catalyst, and stir to disperse evenly; then add sodium periodate and 2-pyridinecarboxylic acid to make the concentration of periodate in the system 45 μmol / L, the concentration of 2-pyridinecarboxylic acid 0.7 mmol / L, and the initial pH approximately 5.0. Stir the reaction at 25℃. Samples are taken at 0 min, 1 min, 2 min, 3 min, and 5 min, respectively. The reaction is terminated by adding sodium sulfite. After filtration, the concentration of SMZ in the solution is measured to obtain the desired concentration. Figure 6 (a).

[0084] from Figure 6 The results in (a) indicate that the 30Fe-Ov prepared in Example 1 1 / 2 MnO2, with the assistance of 2-pyridinecarboxylic acid, can efficiently activate periodate, achieving rapid degradation of SMZ within 5 min. Comparison of the catalytic performance of samples with different Fe doping amounts shows that the Fe doping amount affects the electronic structure of Mn sites on the catalyst surface and the PICA-induced coordination activation efficiency. Example 1, 30Fe-O2... 1 / 2 -MnO2 exhibits superior degradation performance for antibiotic pollutants.

[0085] The effect of different iron sources on the performance of Fe-doped oxygen-rich vacancy δ-MnO2 catalysts was further investigated. The catalysts obtained in Preparation Examples 6 to 8 were used, and SMZ degradation tests were conducted under the same reaction conditions as the 2-pyridinecarboxylic acid-induced periodate heterogeneous activation degradation SMZ performance test in Example 1. The results are as follows: Figure 6 As shown in (b), the Fe-doped oxygen-rich vacancy δ-MnO2 catalysts prepared using ferric chloride hexahydrate, ferric sulfate, and ferric acetate as iron sources can all effectively activate the degradation of SMZ by periodate, with a degradation efficiency of approximately 97% after 5 min. This result indicates that Fe-doped oxygen-rich vacancy δ-MnO2 catalysts with periodate activation properties can still be prepared when soluble iron salts other than ferric nitrate hydrate are used as iron sources.

[0086] 3. Comparative testing of different systems

[0087] To verify the effects of Fe doping, oxygen vacancy construction, and the heterogeneous surface PICA-Mn(Ⅳ) coordination interface on the activated degradation of SMZ by periodate, 45 μmol / L sodium periodate and 0.7 mmol / L 2-pyridinecarboxylic acid were added to every 100 mL of SMZ solution with a concentration of 2 mg / L, and the initial pH was controlled at 5.0. 5 mg of 30Fe-MnO2 from Comparative Example 2 was added to form a 30Fe-MnO2 / PICA / PI system; 5 mg of Ov from Comparative Example 3 was added. 1 / 2 -MnO2 constitutes Ov 1 / 2 -MnO2 / PICA / PI system; add 5mg to prepare 1 30Fe-Ov 1 / 2 -MnO2 constitutes 30Fe-Ov 1 / 2 -MnO2 / PICA / PI system; add 0.4569 mg Mn(NO3)2·4H2O to form Mn 2+ Both / PICA / PI are relative to the control system, and then comparative tests are performed to obtain... Figure 7 .

[0088] Figure 7 This indicates that the 30Fe-MnO2 / PICA / PI system and Ov 1 / 2The MnO2 / PICA / PI system can achieve a certain degree of SMZ degradation, but the degradation effect is lower than that of 30Fe-Ov. 1 / 2 The MnO2 / PICA / PI system indicates a synergistic promoting effect between Fe doping and oxygen vacancy construction, which can improve the activation efficiency of 2-pyridinecarboxylic acid-assisted periodate.

[0089] Meanwhile, Mn 2+ The PICA / PI homogeneous system also exhibits some degradation effect on SMZ, but its degradation efficiency is significantly lower than that of 30Fe-Ov. 1 / 2 The -MnO2 / PICA / PI heterogeneous system was also not superior to the Fe-MnO2 / PICA / PI system.

[0090] This result indicates that, compared to a simple homogeneous Mn² + The Fe-doped oxygen-rich vacancy δ-MnO2 heterogeneous surface coordination activation system constructed in this invention, through the PICA / PI activation process, can significantly improve the activation efficiency of periodate and the degradation performance of SMZ.

[0091] 4. Effects of reaction conditions on the test

[0092] In the preparation of 30Fe-Ov in Example 1 1 / 2 Based on MnO2, the effects of catalyst dosage and periodate concentration on SMZ degradation were investigated, and the results were obtained. Figure 8 (a). In Figure 8 In (a) the reaction system is 100 mL, then Figure 8 (a) 0.10 mL, 0.15 mL, 0.20 mL, 0.30 mL, and 0.40 mL of sodium periodate correspond to final periodate concentrations of 30 μmol / L, 45 μmol / L, 60 μmol / L, 90 μmol / L, and 120 μmol / L, respectively; 2 mg, 5 mg, 10 mg, and 15 mg correspond to catalyst dosages of 20 mg / L, 50 mg / L, 100 mg / L, and 150 mg / L, respectively. Figure 8 (a) The concentration of 2-pyridinecarboxylic acid was 0.7 mmol / L and the initial pH was 5.0.

[0093] exist Figure 8 In (a), both the dosage of Fe-doped oxygen-rich vacancy δ-MnO2 catalyst and the periodate concentration affect the SMZ degradation efficiency. The degradation effect is better when the dosage of Fe-doped oxygen-rich vacancy δ-MnO2 catalyst is 50 mg / L and the periodate concentration is 45 μmol / L.

[0094] Furthermore, the effects of different organic acid ligands on the degradation performance of the system were compared. Specifically, the Fe-doped oxygen-rich vacancy δ-MnO2 catalyst from Preparation Example 1 was used. In 100 mL of a 2 mg / L SMZ solution, 5 mg of Fe-doped oxygen-rich vacancy δ-MnO2 catalyst and 45 μmol / L sodium periodate were added. The only difference was that the 0.7 mmol / L 2-pyridinecarboxylic acid in Example 1 was replaced with different organic acid ligands. Figure 8 (b) In Figure 8 In (b), CA, AA, FA, OA, GA and PICA represent citric acid, ascorbic acid, fumaric acid, oxalic acid, gallic acid and 2-pyridinecarboxylic acid, respectively.

[0095] Figure 8 (b) shows that different organic acids affect 30Fe-Ov 1 / 2 The promoting effects of the MnO2 / PI system varied significantly, with the 2-pyridinecarboxylic acid-assisted system showing superior SMZ degradation performance.

[0096] Further investigation was conducted on the effect of 2-pyridinecarboxylic acid concentration on 30Fe-Ov 1 / 2 The effect of the MnO2 / PICA / PI system on the degradation performance of SMZ is shown in the following results. Figure 8 As shown in (c). Specifically, 5 mg of 30Fe-Ov was added to 100 mL of SMZ solution with a concentration of 2 mg / L. 1 / 2 Using a 30Fe-Ov1 / 2-MnO2 catalyst and sodium periodate, the periodate concentration in the system was set to 45 μmol / L. The concentrations of 2-pyridinecarboxylic acid were set at 0.3 mmol / L, 0.5 mmol / L, 0.7 mmol / L, and 1.0 mmol / L, with an initial pH of approximately 5.0. The degradation reaction was carried out at 25 °C. The results showed that the system could achieve rapid SMZ degradation within the 2-pyridinecarboxylic acid concentration range of 0.3 mmol / L to 1.0 mmol / L. The initial degradation rate was faster at 0.3 mmol / L to 0.7 mmol / L, while the initial degradation rate was relatively lower at 1.0 mmol / L, but SMZ degradation could still be achieved in a short time. This result indicates that 2-pyridinecarboxylic acid concentrations of 0.3 mmol / L to 1.0 mmol / L can effectively assist the degradation of SMZ by 30Fe-Ov1 / 2-MnO2-activated periodate.

[0097] 5. Degradation tests of different typical organic micropollutants

[0098] To verify the applicability of the catalyst of this invention to different typical organic micropollutants, carbamazepine (CBZ), naproxen (NPX), sulfamethoxazole (SMZ), and norfloxacin (NFX) were selected as target pollutants. 100 mL of each catalyst was prepared at a concentration of 2 mg / L, and the catalyst was prepared using the 30Fe-Ov catalyst from Preparation Example 1.1 / 2 -MnO2 was added, along with 5 mg of Fe-doped oxygen-vacancy-rich δ-MnO2 catalyst, 45 μmol / L sodium periodate, and 0.7 mmol / L 2-pyridinecarboxylic acid. The initial pH was 5.0. Degradation tests were conducted, and the following results were obtained: Figure 9 .

[0099] like Figure 9 As shown, 30Fe-Ov 1 / 2 The MnO2 / PICA / PI system exhibited a certain degradation capacity for the aforementioned typical organic micropollutants, with SMZ showing the fastest degradation rate, while the degradation rates of CBZ, NPX, and NFX varied. These results indicate that the catalyst of this invention, under 2-pyridinecarboxylic acid-assisted conditions, can activate periodate to degrade different types of pharmaceutical organic micropollutants, demonstrating a certain range of applicability to various pollutants.

[0100] 6. Cyclic stability test, metal leaching and heterogeneous phase characteristic test

[0101] To evaluate the stability of the catalyst of the present invention, 5 mg of 30Fe-Ov from Preparation Example 1 was used. 1 / 2 The concentrations of MnO2, 45 μmol / L sodium periodate, and 2-pyridinecarboxylic acid were 0.7 mmol / L. The initial pH was 5.0. Multiple cyclic degradation experiments were conducted on 100 mL of a 2 mg / L SMZ solution according to the method in Example 1. After each reaction, the catalyst was recovered, washed sequentially with deionized water and anhydrous ethanol, dried, and used in the next reaction. The concentrations of sodium periodate and 2-pyridinecarboxylic acid were tested in the next round to obtain... Figure 10 .

[0102] from Figure 10 It can be seen that after four cycles of use, 30Fe-Ov 1 / 2 -MnO2 maintained good catalytic activity, and the SMZ degradation efficiency still reached 89%. Meanwhile, the leaching concentrations of Fe and Mn during the cycle were monitored. The results showed that the Fe leaching concentration remained at a low level throughout the cycle, while Mn leaching mainly occurred in the initial cycle and then gradually decreased and stabilized. This indicates that the Fe-doped oxygen-rich vacancy δ-MnO2 catalyst of this invention has good structural stability, resistance to metal loss, and reusability. The low metal leaching also indicates that the system of this invention mainly relies on the heterogeneous surface coordination structure formed by the Mn sites on the solid catalyst surface and 2-pyridinecarboxylic acid for periodate interface activation, rather than the homogeneous Mn-PICA system formed by a large amount of dissolved Mn ions dominating the reaction.

[0103] Finally, it should be noted that the above preparation examples are only used to illustrate the technical solutions of the present invention and are not intended to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to preferred preparation examples, those skilled in the art should understand that modifications or equivalent substitutions can be made to the technical solutions of the present invention without departing from the essence and scope of the technical solutions of the present invention.

Claims

1. A method for constructing a heterogeneous coordination interface using Fe-doped oxygen-rich vacancy δ-MnO2 induced by 2-pyridinecarboxylic acid to activate periodate degradation of organic pollutants, characterized in that, Fe-doped oxygen-rich vacancy δ-MnO2 catalyst, 2-pyridinecarboxylic acid, and periodate were added to water containing organic pollutants. Then, 2-pyridinecarboxylic acid coordinated with the Mn sites on the surface of the Fe-doped oxygen-rich vacancy δ-MnO2 catalyst to form a non-leached heterogeneous surface PICA-Mn(Ⅳ) complex intermediate. Periodate was enriched near the surface active sites of the heterogeneous surface PICA-Mn(Ⅳ) complex intermediate. At the Mn / Fe active sites, periodate underwent interfacial electron transfer and IO bond activation, and induced the heterogeneous surface PICA-Mn(Ⅳ) complex intermediate to generate pentavalent manganese oxygen species and pentavalent iron oxygen species, ultimately achieving the oxidative degradation of organic pollutants. The Fe-doped oxygen-rich vacancy δ-MnO2 catalyst is prepared by reacting potassium permanganate, soluble iron salt and ethylene glycol to generate an Fe-doped manganese dioxide precursor, which is then reduced by a reducing agent.

2. The method according to claim 1, characterized in that: In the water body, the concentration of periodate is 20 μmol / L to 120 μmol / L, and the dosage of Fe-doped oxygen-rich vacancy δ-MnO2 catalyst is 20 mg / L to 100 mg / L. The concentration of 2-pyridinecarboxylic acid is 0.3 mmol / L to 1.0 mmol / L.

3. The method according to claim 1, characterized in that: In the water body, the concentration of periodate was 45 μmol / L.

4. The method according to claim 1, characterized in that: The periodate is at least one of sodium periodate, potassium periodate, or periodic acid.

5. The method according to claim 1, characterized in that: The organic pollutants include at least one of sulfamethoxazole (SMZ), norfloxacin (NFX), carbamazepine (CBZ), or naproxen (NPX).

6. The method according to claim 1, characterized in that, The Fe-doped oxygen-rich vacancy δ-MnO2 catalyst is prepared by the following steps: S1. Add potassium permanganate to deionized water to obtain potassium permanganate solution A; add soluble iron salt to ethylene glycol to obtain iron salt solution B; S2. Add the iron salt solution B obtained in step S1 to the potassium permanganate solution A obtained in step S1 to obtain the Fe-doped manganese dioxide precursor. S3. Dissolve the reducing agent in deionized water to obtain a reducing agent solution; add the Fe-doped manganese dioxide precursor obtained in step S2 to the reducing agent solution for reduction treatment to obtain the Fe-doped oxygen-rich vacancy δ-MnO2 catalyst.

7. The method according to claim 6, characterized in that: In step S2, the molar ratio of the soluble iron salt to potassium permanganate added is (0.03-0.17):1; In step S3, the mass ratio of sodium borohydride to Fe-doped δ-MnO2 precursor is (3.1~12.6):

1.

8. The method according to claim 6, characterized in that: In step S3, the reduction treatment temperature is 15℃~35℃, and the reduction treatment time is 12min~18min.

9. The method according to claim 6, characterized in that: The soluble iron salt is at least one of ferric nitrate, ferric nitrate hydrate, ferric chloride, ferric chloride hydrate, ferric sulfate, ferric sulfate hydrate, ferric acetate, and ferric acetate hydrate.

10. The method according to claim 6, characterized in that: The reducing agent is sodium borohydride.